Changing the future of Oncology.

Clinical/Scientific Presentation and Publication Highlights

Sutro Biopharma to Present at Two Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif., April 8, 2021 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer and...

read more